APO Research
Talk to an analyst

APO RESEARCH · REPORT

Genetically Modified Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Genetically Modified Drug Market Analysis and Forecast 2026-2032

22 December 2025192 pages

Choose your research edition.

Industry ResearchGenetically Modified Drug Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Genetically Modified Drug Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Genetically Modified Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Genetically Modified Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Genetically Modified Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Genetically Modified Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Genetically Modified Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Genetically Modified Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Genetically Modified Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Genetically Modified Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Genetically Modified Drug include Takeda, Sanofi, Johnson & Johnson, Novartis, Merck & Co., Roche, Eli Lilly, Pfizer and GlaxoSmithKline, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Genetically Modified Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Genetically Modified Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Genetically Modified Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Genetically Modified Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Genetically Modified Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Genetically Modified Drug sales, projected growth trends, production technology, application and end-user industry.

Genetically Modified Drug Segment by Company

Takeda

Sanofi

Johnson & Johnson

Novartis

Merck & Co.

Roche

Eli Lilly

Pfizer

GlaxoSmithKline

Baxter

Amgen

Pharming Group NV

LFB Biotechnologies SA

F. Hoffmann-La Roche

Abbott Laboratories

Genetically Modified Drug Segment by Type

Transgenic Animal

Transgenic Plant

Genetically Modified Drug Segment by Application

Hospital

Clinic

Genetically Modified Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genetically Modified Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genetically Modified Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genetically Modified Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Genetically Modified Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Genetically Modified Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Genetically Modified Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Genetically Modified Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Transgenic Animal Major Manufacturers Table 3. Transgenic Plant Major Manufacturers Table 4. Global Genetically Modified Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Genetically Modified Drug Industry Trends Table 8. Genetically Modified Drug Industry Drivers Table 9. Genetically Modified Drug Industry Opportunities and Challenges Table 10. Genetically Modified Drug Industry Restraints Table 11. Global Genetically Modified Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Genetically Modified Drug Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Genetically Modified Drug Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Genetically Modified Drug Revenue Market Share by Region (2021-2026) Table 15. Global Genetically Modified Drug Revenue Market Share by Region (2027-2032) Table 16. Global Genetically Modified Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Genetically Modified Drug Sales by Region (2021-2026) & (k units) Table 18. Global Genetically Modified Drug Sales by Region (2027-2032) & (k units) Table 19. Global Genetically Modified Drug Sales Market Share by Region (2021-2026) Table 20. Global Genetically Modified Drug Sales Market Share by Region (2027-2032) Table 21. Global Genetically Modified Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Genetically Modified Drug Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Genetically Modified Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Genetically Modified Drug Sales Market Share by Manufacturers (2021-2026) Table 25. Global Genetically Modified Drug Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Genetically Modified Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Genetically Modified Drug Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Genetically Modified Drug Manufacturers, Product Type & Application Table 29. Global Genetically Modified Drug Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Genetically Modified Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Genetically Modified Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Genetically Modified Drug Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Genetically Modified Drug Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Genetically Modified Drug Revenue Market Share by Type (2021-2026) Table 36. Global Genetically Modified Drug Revenue Market Share by Type (2027-2032) Table 37. Global Genetically Modified Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Genetically Modified Drug Sales by Type (2021-2026) & (k units) Table 39. Global Genetically Modified Drug Sales by Type (2027-2032) & (k units) Table 40. Global Genetically Modified Drug Sales Market Share by Type (2021-2026) Table 41. Global Genetically Modified Drug Sales Market Share by Type (2027-2032) Table 42. Global Genetically Modified Drug Price by Type (2021-2026) & (US$/unit) Table 43. Global Genetically Modified Drug Price by Type (2027-2032) & (US$/unit) Table 44. Global Genetically Modified Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Genetically Modified Drug Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Genetically Modified Drug Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Genetically Modified Drug Revenue Market Share by Application (2021-2026) Table 48. Global Genetically Modified Drug Revenue Market Share by Application (2027-2032) Table 49. Global Genetically Modified Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Genetically Modified Drug Sales by Application (2021-2026) & (k units) Table 51. Global Genetically Modified Drug Sales by Application (2027-2032) & (k units) Table 52. Global Genetically Modified Drug Sales Market Share by Application (2021-2026) Table 53. Global Genetically Modified Drug Sales Market Share by Application (2027-2032) Table 54. Global Genetically Modified Drug Price by Application (2021-2026) & (US$/unit) Table 55. Global Genetically Modified Drug Price by Application (2027-2032) & (US$/unit) Table 56. Takeda Company Information Table 57. Takeda Business Overview Table 58. Takeda Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. Takeda Genetically Modified Drug Product Portfolio Table 60. Takeda Recent Development Table 61. Sanofi Company Information Table 62. Sanofi Business Overview Table 63. Sanofi Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Sanofi Genetically Modified Drug Product Portfolio Table 65. Sanofi Recent Development Table 66. Johnson & Johnson Company Information Table 67. Johnson & Johnson Business Overview Table 68. Johnson & Johnson Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Johnson & Johnson Genetically Modified Drug Product Portfolio Table 70. Johnson & Johnson Recent Development Table 71. Novartis Company Information Table 72. Novartis Business Overview Table 73. Novartis Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Novartis Genetically Modified Drug Product Portfolio Table 75. Novartis Recent Development Table 76. Merck & Co. Company Information Table 77. Merck & Co. Business Overview Table 78. Merck & Co. Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Merck & Co. Genetically Modified Drug Product Portfolio Table 80. Merck & Co. Recent Development Table 81. Roche Company Information Table 82. Roche Business Overview Table 83. Roche Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Roche Genetically Modified Drug Product Portfolio Table 85. Roche Recent Development Table 86. Eli Lilly Company Information Table 87. Eli Lilly Business Overview Table 88. Eli Lilly Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Eli Lilly Genetically Modified Drug Product Portfolio Table 90. Eli Lilly Recent Development Table 91. Pfizer Company Information Table 92. Pfizer Business Overview Table 93. Pfizer Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Pfizer Genetically Modified Drug Product Portfolio Table 95. Pfizer Recent Development Table 96. GlaxoSmithKline Company Information Table 97. GlaxoSmithKline Business Overview Table 98. GlaxoSmithKline Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. GlaxoSmithKline Genetically Modified Drug Product Portfolio Table 100. GlaxoSmithKline Recent Development Table 101. Baxter Company Information Table 102. Baxter Business Overview Table 103. Baxter Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Baxter Genetically Modified Drug Product Portfolio Table 105. Baxter Recent Development Table 106. Amgen Company Information Table 107. Amgen Business Overview Table 108. Amgen Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Amgen Genetically Modified Drug Product Portfolio Table 110. Amgen Recent Development Table 111. Pharming Group NV Company Information Table 112. Pharming Group NV Business Overview Table 113. Pharming Group NV Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Pharming Group NV Genetically Modified Drug Product Portfolio Table 115. Pharming Group NV Recent Development Table 116. LFB Biotechnologies SA Company Information Table 117. LFB Biotechnologies SA Business Overview Table 118. LFB Biotechnologies SA Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. LFB Biotechnologies SA Genetically Modified Drug Product Portfolio Table 120. LFB Biotechnologies SA Recent Development Table 121. F. Hoffmann-La Roche Company Information Table 122. F. Hoffmann-La Roche Business Overview Table 123. F. Hoffmann-La Roche Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. F. Hoffmann-La Roche Genetically Modified Drug Product Portfolio Table 125. F. Hoffmann-La Roche Recent Development Table 126. Abbott Laboratories Company Information Table 127. Abbott Laboratories Business Overview Table 128. Abbott Laboratories Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Abbott Laboratories Genetically Modified Drug Product Portfolio Table 130. Abbott Laboratories Recent Development Table 131. North America Genetically Modified Drug Revenue by Type (2021-2026) & (US$ Million) Table 132. North America Genetically Modified Drug Revenue by Type (2027-2032) & (US$ Million) Table 133. North America Genetically Modified Drug Sales by Type (2021-2026) & (k units) Table 134. North America Genetically Modified Drug Sales by Type (2027-2032) & (k units) Table 135. North America Genetically Modified Drug Sales Price by Type (2021-2026) & (US$/unit) Table 136. North America Genetically Modified Drug Sales Price by Type (2027-2032) & (US$/unit) Table 137. North America Genetically Modified Drug Revenue by Application (2021-2026) & (US$ Million) Table 138. North America Genetically Modified Drug Revenue by Application (2027-2032) & (US$ Million) Table 139. North America Genetically Modified Drug Sales by Application (2021-2026) & (k units) Table 140. North America Genetically Modified Drug Sales by Application (2027-2032) & (k units) Table 141. North America Genetically Modified Drug Sales Price by Application (2021-2026) & (US$/unit) Table 142. North America Genetically Modified Drug Sales Price by Application (2027-2032) & (US$/unit) Table 143. North America Genetically Modified Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. North America Genetically Modified Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 145. North America Genetically Modified Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 146. North America Genetically Modified Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 147. North America Genetically Modified Drug Sales by Country (2021-2026) & (k units) Table 148. North America Genetically Modified Drug Sales by Country (2027-2032) & (k units) Table 149. North America Genetically Modified Drug Sales Price by Country (2021-2026) & (US$/unit) Table 150. North America Genetically Modified Drug Sales Price by Country (2027-2032) & (US$/unit) Table 151. United States Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 152. Canada Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 153. Mexico Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 154. Europe Genetically Modified Drug Revenue by Type (2021-2026) & (US$ Million) Table 155. Europe Genetically Modified Drug Revenue by Type (2027-2032) & (US$ Million) Table 156. Europe Genetically Modified Drug Sales by Type (2021-2026) & (k units) Table 157. Europe Genetically Modified Drug Sales by Type (2027-2032) & (k units) Table 158. Europe Genetically Modified Drug Sales Price by Type (2021-2026) & (US$/unit) Table 159. Europe Genetically Modified Drug Sales Price by Type (2027-2032) & (US$/unit) Table 160. Europe Genetically Modified Drug Revenue by Application (2021-2026) & (US$ Million) Table 161. Europe Genetically Modified Drug Revenue by Application (2027-2032) & (US$ Million) Table 162. Europe Genetically Modified Drug Sales by Application (2021-2026) & (k units) Table 163. Europe Genetically Modified Drug Sales by Application (2027-2032) & (k units) Table 164. Europe Genetically Modified Drug Sales Price by Application (2021-2026) & (US$/unit) Table 165. Europe Genetically Modified Drug Sales Price by Application (2027-2032) & (US$/unit) Table 166. Europe Genetically Modified Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 167. Europe Genetically Modified Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 168. Europe Genetically Modified Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 169. Europe Genetically Modified Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 170. Europe Genetically Modified Drug Sales by Country (2021-2026) & (k units) Table 171. Europe Genetically Modified Drug Sales by Country (2027-2032) & (k units) Table 172. Europe Genetically Modified Drug Sales Price by Country (2021-2026) & (US$/unit) Table 173. Europe Genetically Modified Drug Sales Price by Country (2027-2032) & (US$/unit) Table 174. Germany Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 175. France Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 176. U.K. Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 177. Italy Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 178. Russia Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 179. Spain Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 180. Netherlands Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 181. Switzerland Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 182. Sweden Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 183. Poland Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 184. China Genetically Modified Drug Revenue by Type (2021-2026) & (US$ Million) Table 185. China Genetically Modified Drug Revenue by Type (2027-2032) & (US$ Million) Table 186. China Genetically Modified Drug Sales by Type (2021-2026) & (k units) Table 187. China Genetically Modified Drug Sales by Type (2027-2032) & (k units) Table 188. China Genetically Modified Drug Sales Price by Type (2021-2026) & (US$/unit) Table 189. China Genetically Modified Drug Sales Price by Type (2027-2032) & (US$/unit) Table 190. China Genetically Modified Drug Revenue by Application (2021-2026) & (US$ Million) Table 191. China Genetically Modified Drug Revenue by Application (2027-2032) & (US$ Million) Table 192. China Genetically Modified Drug Sales by Application (2021-2026) & (k units) Table 193. China Genetically Modified Drug Sales by Application (2027-2032) & (k units) Table 194. China Genetically Modified Drug Sales Price by Application (2021-2026) & (US$/unit) Table 195. China Genetically Modified Drug Sales Price by Application (2027-2032) & (US$/unit) Table 196. Asia Genetically Modified Drug Revenue by Type (2021-2026) & (US$ Million) Table 197. Asia Genetically Modified Drug Revenue by Type (2027-2032) & (US$ Million) Table 198. Asia Genetically Modified Drug Sales by Type (2021-2026) & (k units) Table 199. Asia Genetically Modified Drug Sales by Type (2027-2032) & (k units) Table 200. Asia Genetically Modified Drug Sales Price by Type (2021-2026) & (US$/unit) Table 201. Asia Genetically Modified Drug Sales Price by Type (2027-2032) & (US$/unit) Table 202. Asia Genetically Modified Drug Revenue by Application (2021-2026) & (US$ Million) Table 203. Asia Genetically Modified Drug Revenue by Application (2027-2032) & (US$ Million) Table 204. Asia Genetically Modified Drug Sales by Application (2021-2026) & (k units) Table 205. Asia Genetically Modified Drug Sales by Application (2027-2032) & (k units) Table 206. Asia Genetically Modified Drug Sales Price by Application (2021-2026) & (US$/unit) Table 207. Asia Genetically Modified Drug Sales Price by Application (2027-2032) & (US$/unit) Table 208. Asia Genetically Modified Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 209. Asia Genetically Modified Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 210. Asia Genetically Modified Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 211. Asia Genetically Modified Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 212. Asia Genetically Modified Drug Sales by Country (2021-2026) & (k units) Table 213. Asia Genetically Modified Drug Sales by Country (2027-2032) & (k units) Table 214. Asia Genetically Modified Drug Sales Price by Country (2021-2026) & (US$/unit) Table 215. Asia Genetically Modified Drug Sales Price by Country (2027-2032) & (US$/unit) Table 216. Japan Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 217. South Korea Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 218. India Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 219. Australia Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 220. Taiwan Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 221. Southeast Asia Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 222. SAMEA Genetically Modified Drug Revenue by Type (2021-2026) & (US$ Million) Table 223. SAMEA Genetically Modified Drug Revenue by Type (2027-2032) & (US$ Million) Table 224. SAMEA Genetically Modified Drug Sales by Type (2021-2026) & (k units) Table 225. SAMEA Genetically Modified Drug Sales by Type (2027-2032) & (k units) Table 226. SAMEA Genetically Modified Drug Sales Price by Type (2021-2026) & (US$/unit) Table 227. SAMEA Genetically Modified Drug Sales Price by Type (2027-2032) & (US$/unit) Table 228. SAMEA Genetically Modified Drug Revenue by Application (2021-2026) & (US$ Million) Table 229. SAMEA Genetically Modified Drug Revenue by Application (2027-2032) & (US$ Million) Table 230. SAMEA Genetically Modified Drug Sales by Application (2021-2026) & (k units) Table 231. SAMEA Genetically Modified Drug Sales by Application (2027-2032) & (k units) Table 232. SAMEA Genetically Modified Drug Sales Price by Application (2021-2026) & (US$/unit) Table 233. SAMEA Genetically Modified Drug Sales Price by Application (2027-2032) & (US$/unit) Table 234. SAMEA Genetically Modified Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 235. SAMEA Genetically Modified Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 236. SAMEA Genetically Modified Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 237. SAMEA Genetically Modified Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 238. SAMEA Genetically Modified Drug Sales by Country (2021-2026) & (k units) Table 239. SAMEA Genetically Modified Drug Sales by Country (2027-2032) & (k units) Table 240. SAMEA Genetically Modified Drug Sales Price by Country (2021-2026) & (US$/unit) Table 241. SAMEA Genetically Modified Drug Sales Price by Country (2027-2032) & (US$/unit) Table 242. Brazil Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 243. Argentina Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 244. Chile Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 245. Colombia Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 246. Peru Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 247. Saudi Arabia Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 248. Israel Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 249. UAE Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 250. Turkey Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 251. Iran Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 252. Egypt Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Table 253. Key Raw Materials Table 254. Raw Materials Key Suppliers Table 255. Genetically Modified Drug Distributors List Table 256. Genetically Modified Drug Customers List Table 257. Research Programs/Design for This Report Table 258. Authors List of This Report Table 259. Secondary Sources Table 260. Primary Sources List of Figures Figure 1. Genetically Modified Drug Image Figure 2. Global Genetically Modified Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Genetically Modified Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Transgenic Animal Image Figure 5. Transgenic Plant Image Figure 6. Global Genetically Modified Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Genetically Modified Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Global Genetically Modified Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Figure 12. Global Genetically Modified Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Genetically Modified Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Genetically Modified Drug Revenue Market Share by Region (2021-2032) Figure 15. Global Genetically Modified Drug Sales (2021-2032) & (k units) Figure 16. Global Genetically Modified Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Genetically Modified Drug Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Genetically Modified Drug Sales YoY (2021-2032) & (k units) Figure 19. Europe Genetically Modified Drug Sales YoY (2021-2032) & (k units) Figure 20. China Genetically Modified Drug Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Genetically Modified Drug Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Genetically Modified Drug Sales YoY (2021-2032) & (k units) Figure 23. Global Genetically Modified Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Genetically Modified Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Genetically Modified Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Genetically Modified Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Genetically Modified Drug Revenue Market Share by Type (2021-2032) Figure 29. Global Genetically Modified Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Genetically Modified Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Genetically Modified Drug Sales Market Share by Type (2021-2032) Figure 32. Global Genetically Modified Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Genetically Modified Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Genetically Modified Drug Revenue Market Share by Application (2021-2032) Figure 35. Global Genetically Modified Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Genetically Modified Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Genetically Modified Drug Sales Market Share by Application (2021-2032) Figure 38. North America Genetically Modified Drug Revenue Share by Type (2021-2032) Figure 39. North America Genetically Modified Drug Sales Share by Type (2021-2032) Figure 40. North America Genetically Modified Drug Revenue Share by Application (2021-2032) Figure 41. North America Genetically Modified Drug Sales Share by Application (2021-2032) Figure 42. North America Genetically Modified Drug Revenue Share by Country (2021-2032) Figure 43. North America Genetically Modified Drug Sales Share by Country (2021-2032) Figure 44. Europe Genetically Modified Drug Revenue Share by Type (2021-2032) Figure 45. Europe Genetically Modified Drug Sales Share by Type (2021-2032) Figure 46. Europe Genetically Modified Drug Revenue Share by Application (2021-2032) Figure 47. Europe Genetically Modified Drug Sales Share by Application (2021-2032) Figure 48. Europe Genetically Modified Drug Revenue Share by Country (2021-2032) Figure 49. Europe Genetically Modified Drug Sales Share by Country (2021-2032) Figure 50. China Genetically Modified Drug Revenue Share by Type (2021-2032) Figure 51. China Genetically Modified Drug Sales Share by Type (2021-2032) Figure 52. China Genetically Modified Drug Revenue Share by Application (2021-2032) Figure 53. China Genetically Modified Drug Sales Share by Application (2021-2032) Figure 54. Asia Genetically Modified Drug Revenue Share by Type (2021-2032) Figure 55. Asia Genetically Modified Drug Sales Share by Type (2021-2032) Figure 56. Asia Genetically Modified Drug Revenue Share by Application (2021-2032) Figure 57. Asia Genetically Modified Drug Sales Share by Application (2021-2032) Figure 58. Asia Genetically Modified Drug Revenue Share by Country (2021-2032) Figure 59. Asia Genetically Modified Drug Sales Share by Country (2021-2032) Figure 60. SAMEA Genetically Modified Drug Revenue Share by Type (2021-2032) Figure 61. SAMEA Genetically Modified Drug Sales Share by Type (2021-2032) Figure 62. SAMEA Genetically Modified Drug Revenue Share by Application (2021-2032) Figure 63. SAMEA Genetically Modified Drug Sales Share by Application (2021-2032) Figure 64. SAMEA Genetically Modified Drug Revenue Share by Country (2021-2032) Figure 65. SAMEA Genetically Modified Drug Sales Share by Country (2021-2032) Figure 66. Genetically Modified Drug Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Genetically Modified Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Transgenic Animal
  • Transgenic Plant
Applications
  • Hospital
  • Clinic
Companies covered
  • Takeda
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck & Co.
  • Roche
  • Eli Lilly
  • Pfizer
  • GlaxoSmithKline
  • Baxter
  • Amgen
  • Pharming Group NV
  • LFB Biotechnologies SA
  • F. Hoffmann-La Roche
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Genetically Modified Drug Market by Type
  3. 1.2.1 Global Genetically Modified Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Transgenic Animal
  5. 1.2.3 Transgenic Plant
  6. 1.3 Genetically Modified Drug Market by Application
  7. 1.3.1 Global Genetically Modified Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Genetically Modified Drug Market Dynamics
  1. 2.1 Genetically Modified Drug Industry Trends
  2. 2.2 Genetically Modified Drug Industry Drivers
  3. 2.3 Genetically Modified Drug Industry Opportunities and Challenges
  4. 2.4 Genetically Modified Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Genetically Modified Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Genetically Modified Drug Revenue by Region
  3. 3.2.1 Global Genetically Modified Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Genetically Modified Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Genetically Modified Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Genetically Modified Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Genetically Modified Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Genetically Modified Drug Sales by Region
  9. 3.4.1 Global Genetically Modified Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Genetically Modified Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Genetically Modified Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Genetically Modified Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Genetically Modified Drug Revenue by Manufacturers
  2. 4.1.1 Global Genetically Modified Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Genetically Modified Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Genetically Modified Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Genetically Modified Drug Sales by Manufacturers
  6. 4.2.1 Global Genetically Modified Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Genetically Modified Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Genetically Modified Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Genetically Modified Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Genetically Modified Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Genetically Modified Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Genetically Modified Drug Manufacturers, Product Type & Application
  13. 4.7 Global Genetically Modified Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Genetically Modified Drug Market CR5 and HHI
  16. 4.8.2 2025 Genetically Modified Drug Tier 1, Tier 2, and Tier 3
5 Genetically Modified Drug Market by Type
  1. 5.1 Global Genetically Modified Drug Revenue by Type
  2. 5.1.1 Global Genetically Modified Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Genetically Modified Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Genetically Modified Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Genetically Modified Drug Sales by Type
  6. 5.2.1 Global Genetically Modified Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Genetically Modified Drug Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Genetically Modified Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Genetically Modified Drug Price by Type
6 Genetically Modified Drug Market by Application
  1. 6.1 Global Genetically Modified Drug Revenue by Application
  2. 6.1.1 Global Genetically Modified Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Genetically Modified Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Genetically Modified Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Genetically Modified Drug Sales by Application
  6. 6.2.1 Global Genetically Modified Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Genetically Modified Drug Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Genetically Modified Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Genetically Modified Drug Price by Application
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Genetically Modified Drug Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 Sanofi
  8. 7.2.1 Sanofi Company Information
  9. 7.2.2 Sanofi Business Overview
  10. 7.2.3 Sanofi Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Genetically Modified Drug Product Portfolio
  12. 7.2.5 Sanofi Recent Developments
  13. 7.3 Johnson & Johnson
  14. 7.3.1 Johnson & Johnson Company Information
  15. 7.3.2 Johnson & Johnson Business Overview
  16. 7.3.3 Johnson & Johnson Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Johnson & Johnson Genetically Modified Drug Product Portfolio
  18. 7.3.5 Johnson & Johnson Recent Developments
  19. 7.4 Novartis
  20. 7.4.1 Novartis Company Information
  21. 7.4.2 Novartis Business Overview
  22. 7.4.3 Novartis Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Novartis Genetically Modified Drug Product Portfolio
  24. 7.4.5 Novartis Recent Developments
  25. 7.5 Merck & Co.
  26. 7.5.1 Merck & Co. Company Information
  27. 7.5.2 Merck & Co. Business Overview
  28. 7.5.3 Merck & Co. Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Merck & Co. Genetically Modified Drug Product Portfolio
  30. 7.5.5 Merck & Co. Recent Developments
  31. 7.6 Roche
  32. 7.6.1 Roche Company Information
  33. 7.6.2 Roche Business Overview
  34. 7.6.3 Roche Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Roche Genetically Modified Drug Product Portfolio
  36. 7.6.5 Roche Recent Developments
  37. 7.7 Eli Lilly
  38. 7.7.1 Eli Lilly Company Information
  39. 7.7.2 Eli Lilly Business Overview
  40. 7.7.3 Eli Lilly Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Eli Lilly Genetically Modified Drug Product Portfolio
  42. 7.7.5 Eli Lilly Recent Developments
  43. 7.8 Pfizer
  44. 7.8.1 Pfizer Company Information
  45. 7.8.2 Pfizer Business Overview
  46. 7.8.3 Pfizer Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Pfizer Genetically Modified Drug Product Portfolio
  48. 7.8.5 Pfizer Recent Developments
  49. 7.9 GlaxoSmithKline
  50. 7.9.1 GlaxoSmithKline Company Information
  51. 7.9.2 GlaxoSmithKline Business Overview
  52. 7.9.3 GlaxoSmithKline Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 GlaxoSmithKline Genetically Modified Drug Product Portfolio
  54. 7.9.5 GlaxoSmithKline Recent Developments
  55. 7.10 Baxter
  56. 7.10.1 Baxter Company Information
  57. 7.10.2 Baxter Business Overview
  58. 7.10.3 Baxter Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Baxter Genetically Modified Drug Product Portfolio
  60. 7.10.5 Baxter Recent Developments
  61. 7.11 Amgen
  62. 7.11.1 Amgen Company Information
  63. 7.11.2 Amgen Business Overview
  64. 7.11.3 Amgen Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Amgen Genetically Modified Drug Product Portfolio
  66. 7.11.5 Amgen Recent Developments
  67. 7.12 Pharming Group NV
  68. 7.12.1 Pharming Group NV Company Information
  69. 7.12.2 Pharming Group NV Business Overview
  70. 7.12.3 Pharming Group NV Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Pharming Group NV Genetically Modified Drug Product Portfolio
  72. 7.12.5 Pharming Group NV Recent Developments
  73. 7.13 LFB Biotechnologies SA
  74. 7.13.1 LFB Biotechnologies SA Company Information
  75. 7.13.2 LFB Biotechnologies SA Business Overview
  76. 7.13.3 LFB Biotechnologies SA Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 LFB Biotechnologies SA Genetically Modified Drug Product Portfolio
  78. 7.13.5 LFB Biotechnologies SA Recent Developments
  79. 7.14 F. Hoffmann-La Roche
  80. 7.14.1 F. Hoffmann-La Roche Company Information
  81. 7.14.2 F. Hoffmann-La Roche Business Overview
  82. 7.14.3 F. Hoffmann-La Roche Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 F. Hoffmann-La Roche Genetically Modified Drug Product Portfolio
  84. 7.14.5 F. Hoffmann-La Roche Recent Developments
  85. 7.15 Abbott Laboratories
  86. 7.15.1 Abbott Laboratories Company Information
  87. 7.15.2 Abbott Laboratories Business Overview
  88. 7.15.3 Abbott Laboratories Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Abbott Laboratories Genetically Modified Drug Product Portfolio
  90. 7.15.5 Abbott Laboratories Recent Developments
8 North America
  1. 8.1 North America Genetically Modified Drug Market Size by Type
  2. 8.1.1 North America Genetically Modified Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Genetically Modified Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Genetically Modified Drug Price by Type (2021-2032)
  5. 8.2 North America Genetically Modified Drug Market Size by Application
  6. 8.2.1 North America Genetically Modified Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Genetically Modified Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Genetically Modified Drug Price by Application (2021-2032)
  9. 8.3 North America Genetically Modified Drug Market Size by Country
  10. 8.3.1 North America Genetically Modified Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Genetically Modified Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Genetically Modified Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Genetically Modified Drug Market Size by Type
  2. 9.1.1 Europe Genetically Modified Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Genetically Modified Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Genetically Modified Drug Price by Type (2021-2032)
  5. 9.2 Europe Genetically Modified Drug Market Size by Application
  6. 9.2.1 Europe Genetically Modified Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Genetically Modified Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Genetically Modified Drug Price by Application (2021-2032)
  9. 9.3 Europe Genetically Modified Drug Market Size by Country
  10. 9.3.1 Europe Genetically Modified Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Genetically Modified Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Genetically Modified Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Genetically Modified Drug Market Size by Type
  2. 10.1.1 China Genetically Modified Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Genetically Modified Drug Sales by Type (2021-2032)
  4. 10.1.3 China Genetically Modified Drug Price by Type (2021-2032)
  5. 10.2 China Genetically Modified Drug Market Size by Application
  6. 10.2.1 China Genetically Modified Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Genetically Modified Drug Sales by Application (2021-2032)
  8. 10.2.3 China Genetically Modified Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Genetically Modified Drug Market Size by Type
  2. 11.1.1 Asia Genetically Modified Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Genetically Modified Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Genetically Modified Drug Price by Type (2021-2032)
  5. 11.2 Asia Genetically Modified Drug Market Size by Application
  6. 11.2.1 Asia Genetically Modified Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Genetically Modified Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Genetically Modified Drug Price by Application (2021-2032)
  9. 11.3 Asia Genetically Modified Drug Market Size by Country
  10. 11.3.1 Asia Genetically Modified Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Genetically Modified Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Genetically Modified Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Genetically Modified Drug Market Size by Type
  2. 12.1.1 SAMEA Genetically Modified Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Genetically Modified Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Genetically Modified Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Genetically Modified Drug Market Size by Application
  6. 12.2.1 SAMEA Genetically Modified Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Genetically Modified Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Genetically Modified Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Genetically Modified Drug Market Size by Country
  10. 12.3.1 SAMEA Genetically Modified Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Genetically Modified Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Genetically Modified Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Genetically Modified Drug Value Chain Analysis
  2. 13.1.1 Genetically Modified Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Genetically Modified Drug Production Mode & Process
  6. 13.2 Genetically Modified Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Genetically Modified Drug Distributors
  9. 13.2.3 Genetically Modified Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst